Financials · mywealthgrid

Loading page…

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	14,630	15,219	16,362	17,132	19,160	21,763	22,753	25,774	27,548	28,163
COGS	5,317	5,438	5,784	5,991	7,352	8,496	8,252	8,820	8,929	9,549
Gross profit	9,313	9,781	10,578	11,141	11,808	13,268	14,501	16,955	18,619	18,613
	—	—	—	7,982	7,568	8,728	9,476	10,665	11,513	12,739
	—	—	—	3,159	4,240	4,540	5,024	6,289	7,106	5,875
OPM %	—	—	—	18.4%	22.1%	20.9%	22.1%	24.4%	25.8%	20.9%
Depreciation	—	—	—	1,175	1,068	1,052	1,172	1,051	1,107	1,211
Interest	159	114	168	197	161	106	110	90	62	54
	306	435	529	344	266	99	293	552	862	606
Profit before tax	1,222	1,669	2,079	2,131	3,277	3,480	4,036	5,700	6,799	5,216
Tax	—	250	570	631	889	934	1,203	1,547	1,530	1,354
Tax %	—	15%	27.4%	29.6%	27.1%	26.8%	29.8%	27.1%	22.5%	26%
	1,035	1,417	1,492	1,500	2,389	2,547	2,833	4,154	5,269	3,862
PAT margin %	7.1%	9.3%	9.1%	8.8%	12.5%	11.7%	12.5%	16.1%	19.1%	13.7%
EPS (₹)	—	—	—	19.2	29.8	31.2	34.7	51.1	65.3	48
EPS adjusted (₹)	12.5	17.5	19	19.2	29.8	31.2	34.7	51.1	65.3	48
	—	—	—	15.6%	16.8%	16%	24.5%	25.5%	24.5%	27.1%
Annual report	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	161	161	161	161	161	161	161	161	161	162	162
Reserves	10,485	12,383	14,068	14,851	15,602	18,165	20,680	23,246	26,545	31,032	34,270
Minority interest	332	438	352	332	294	259	276	306	96	96	88
	1,702	4,113	4,098	4,316	2,816	1,756	824	520	247	92	258
	2,968	3,943	4,181	4,303	4,789	4,811	5,160	5,229	5,668	6,006	7,718
Total equity & liabilities	15,647	21,037	22,861	23,963	23,663	25,152	27,101	29,463	32,718	37,387	42,496
	6,730	9,490	9,949	9,547	9,236	9,056	9,296	9,101	9,494	9,895	12,434
CWIP	535	719	512	331	421	571	383	689	864	1,213	1,586
Investments	639	973	1,259	2,554	1,471	2,710	2,551	3,722	5,563	8,044	8,223
	7,743	9,855	11,140	11,532	12,535	12,815	14,871	15,951	16,797	18,235	20,252
Total assets	15,647	21,037	22,861	23,963	23,663	25,152	27,101	29,463	32,718	37,387	42,496

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs.

Source XBRL ↗

Latest reported period · 31 Mar 2025 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities
Pharmaceuticals	26,446.33	6,872.29	0	0
New ventures	1,303.36	10.53	0	0

SegmentFigure

New Ventures · revenue

₹ crore by fiscal year

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1,741	2,382	1,463	1,691	3,068	3,755	3,326	3,238	4,134	5,005	3,940
	-4,523	-1,310	-854	-1,669	104	-2,387	-1,872	-2,389	-2,988	-3,691	-2,326
	3,104	-1,326	-385	-349	-2,949	-1,330	-1,600	-958	-1,200	-1,293	-1,234
Net cash flow	322	-254	223	-326	224	38	-146	-109	-55	21	380
Free cash flow	664	2,382	757	1,331	2,496	3,126	2,782	2,397	3,036	3,843	2,341
CFO / Operating profit %	—	—	—	—	95.7%	88.3%	73.1%	64.4%	65.7%	70.2%	67%